cost-effective clinical development with strategic clinical innovation organization

22
BBCR CONSULTING Cost-Effective Clinical Development With BBCR Consulting 1 ST Strategic Clinical Innovation Organization 1

Upload: bbcr-consulting

Post on 17-Jan-2017

281 views

Category:

Healthcare


0 download

TRANSCRIPT

1

BBCR CONSULTING

Cost-Effective Clinical DevelopmentWith BBCR Consulting

1ST Strategic Clinical Innovation Organization

2

AGENDA

o SCIO Introduction• SCIO Concept• SCIO Impacts on Clinical Trials

o BBCR Consulting• BBCR Values• BBCR Method• Experienced Team

3

BBCR Consulting is the 1ST Strategic Clinical Innovation Organization

“Strategy and Roadmap for cost-efficiency and risk-management in clinical trials from pre-clinical to

market.”

SCIO Concept

4

Increasing Complexity

of Trial Protocols

Patient Enrollment

Patient Retention

Decline in R&D

Productivity

Reasons Why Clinical Trials Are So Expensive

Slow Time-to-Market

Low Development Success Rate

Capitalized Costs have

doubled

Inefficiency

5

Phase I Phase II Phase III Approval MarketPre-clinicalDiscovery

Traditional Drug Development Process

Pharmaceutical industry has been developing drug this way for decades; people believe it to be the RIGHT way.

Clinical Tactics

6

Phase I Phase II Phase III Approval MarketPre-clinicalDiscovery Pre-IND

• Regulatory Strategy

• Clinical Strategy• Clinical/

Regulatory Roadmap

Innovative Drug Development Process

Pre-Clinical Data Regulatory Medical

Information

Marketing Analysis

KoLs FeedbacksTIMING

INFORMATION

7

GAP Pre-

clinicalDiscovery

Phase I Phase II Phase III

Clinical Tactics (CRO)

Only Pre-clinical Data

• High Risk• High Cost• Low

Efficiency

Only Pre-clinical Data

Clinical Strategy (SCIO)Pre-

clinicalDiscovery

Phase I Phase II Phase III

Clinical Tactics (CRO)

• Pre-clinical Data• Medical Information• Regulatory

Information• Marketing Analysis• KoL’s Feedback

• Data Interpretation• Medical Evaluation• Regulatory

Pathfinding• Marketing

Understanding• Strategy Formation

Cost-Effective Clinical Trials

• Regulatory Strategy

• Clinical Strategy• Clinical/

Regulatory Roadmap

• Simplify Clinical Research

• Customize Clinical Strategy

• Manage Risk

9

BBCR The First SCIO

BBCR CONSULTING is the First SCIO that

• Has a comprehensive understanding of the importance of strategy in clinical trials

• Has a seasoned Board of Advisors and a robust industrial network to provide supports

• With highest care and professionalism, we Customizes clinical and regulatory strategy for each life science product to ensure its best opportunity to succeed

• Devises and standardizes SCIO procedures to ensure the best quality services provided, and thus cost-effective clinical trials being realized

10

SCIO ImpactsCost-effective & Risks-Reduced Clinical Trials

11

12

BBCR ValuesStrategic Clinical Innovation Experts

13

Best Team

Best Quality

Best Services

14

NETWORK

INNOVATION

INTEGRITY

15

INTEGRITY

INNOVATION

NETWORKRegulatory

Strategy and Regulators’ Feedbacks

Customize Clinical Strategy Prior to

First-In-ManStreamline Trial Design for Cost-Efficiency and

Risk ManagementClinical/Regulatory

Roadmap for Better Resources

Allocation

Regulatory Uncertainties

Universal Step-by-step Clinical

Development for Different Products

Clinical Development

Complexity and Associated Risks

Difficulty in Planning

Resources

Challenges Solutions

16

BBCR MethodStrategic Clinical Innovation Experts

17

Engagement

Vision Alignment ● Objectives ● Methodology ● Actions ● Timing

● Discovery● Solution Search● Strategy● Confirmation● Client Approval

● Clinical Roadmap● Regulatory Roadmap● Clinical Strategy● Regulatory Strategy

Cost-Effective Clinical Trials

18

BBCR Experienced Team“SCIO concept requires a strong and experienced team!”

20

Candida Fratazzi Federico Goodsaid Claudio Carini

President/CEO• Immunology• Inflammation• Orphan • Clinical

Strategy• Trial Design

M.D. PhD M.D. / PhD / FRCPath

Board of Advisor• FDA• Regulatory• Biologics• Orphan

Board of Advisor• Immunology• Autoimmune • Biomarkers• Precision

Medicine• Epigenetics

Lori Perreira Zahra Shahrokh Wade FoxPhD

Board of Advisor• Reimburseme

nt strategy• Orphan• Gene Therapy

Board of Advisor• CMC• Biologics• Small

Molecule• Biotechnology

Product

Board of Advisor• Market

Analysis• Medical

Devices• Medical

Technology

22

CONTACT USFind us! Drop Your Questions Online!

Location 1 Broadway, Cambridge MA, USA 02142Phone +1(617)401-2327Email [email protected]

You Ask! We Answer!For an immediate help, we created “You Ask We Answer” Section on our website to provide further assistance with any question you may have.www.BBCRConsulting.com